What Researchers Did
This study reviewed the current medical treatments and future directions for critical limb ischemia (CLI).
What They Found
Critical limb ischemia (CLI) affects approximately 500-1000 new cases per year per million people, carrying a high risk of major amputation and cardiovascular morbidity and mortality. Researchers found that prompt surgical or endovascular revascularization is recommended for limb salvage, alongside cardiovascular risk reduction therapies and adjunctive pharmacotherapy with antithrombotic drugs, statins, and beta-blockers.
What This Means for Canadian Patients
Canadian patients with critical limb ischemia should prioritize prompt revascularization procedures and adhere to cardiovascular risk reduction therapies, including antiplatelet drugs and statins. Managing risk factors like diabetes and receiving dedicated wound care are crucial for preventing limb loss and improving overall quality of life.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a review article, this study synthesizes existing literature without presenting new primary data or clinical trial results.